-
November 6: Alternative Economic Assessment for Expressing Healthcare Value and Informing Resource Allocation Decisions - In Person at ISPOR Europe 2022
-
November 6: Statistical Methods for Health Economics & Outcomes Research - In Person at ISPOR Europe 2022
-
November 6: Applied Cost-Effectiveness Modeling with R - In Person at ISPOR Europe 2022
-
November 6: Elements of Pharmaceutical/Biotech Pricing - In Person at ISPOR Europe 2022
-
November 6: Reimbursement Systems for Pharmaceuticals in Europe - In Person at ISPOR Europe 2022
-
November 6: Going Beyond the Standard: Exploring Advanced Survival Modeling Techniques - In Person at ISPOR Europe 2022
-
November 6: Advanced Decision Modeling for Health Economic Evaluations - In Person at ISPOR Europe 2022
-
November 6: Health Economic Modeling in R: A Hands-on Introduction - In Person at ISPOR Europe 2022
-
November 6: Introduction to the Design & Analysis of Observational Studies of Treatment Effects Using Retrospective Data Sources - In Person at ISPOR Europe 2022
-
November 6: Risk-Sharing/Performance-Based Arrangements in Developing Countries - In Person at ISPOR Europe 2022
-
HEOR Theater - Inclusive & Representative: How RWE Can Help to Fill Gaps Left by Clinical Trials
1:00PM-1:45PM EDT
-
HEOR Theater - Patients and Caregivers as Partners in Health Preference Research
11:00AM-11:45AM EDT
-
October 19: Metamodeling for Simulation-Based Optimization of Strategies in Healthcare- Virtual
-
Can the Benefits From Biosimilars be Sustainably Increased? Policy Recommendations for Europe, Middle East and Canada
-
October 12-13: Study Design with Real-World Data- Virtual
-
Health Insurance in Africa: Sustainability in Focus
-
Souring On SUCRAs: When Treatment Ranking Goes Wrong
-
Availability and Access to Innovative Therapies in Latin America
-
Fit for Local Context? Establishing or Improving Deliberative Processes for HTA
-
On the Validity of Statistical Analyses with Privacy-Preserving Synthetic Data
